SecFilingDex

GOLDENWELL BIOTECH, INC.

39 SEC EDGAR filings indexed (CIK 0001800373) across 11 form types.

Filing profile

GOLDENWELL BIOTECH, INC. (GWLL) has 39 SEC filings indexed on SecFilingDex, across 11 form types filed over roughly 6 years, from February 21, 2020 to August 14, 2026. The filer is classified under Food & Kindred Products (SIC 2000).

Its most frequent disclosure is the 10-Q (Quarterly report) with 8 filings — Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters. 10 of these filings were disclosed in the twelve months to August 14, 2026. 10 of the 39 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 810-QQuarterly report · quarterly
  • 610-KAnnual report · annual
  • 68-KMaterial event · event-driven
  • 5S-1/AIPO registration · event-driven (pre-ipo)
  • 410-Q/AQuarterly report · quarterly
  • 3Form 3Initial insider ownership · within 10 days of becoming an insider
  • 3SC 13D5%+ activist stake · event-driven (within 10 days)
  • 1SC 13G5%+ passive stake · event-driven
  • 110-K/AAnnual report · annual
  • 1424B3Updated prospectus · event-driven
  • 1S-1IPO registration · event-driven (pre-ipo)

Profile derived from 39 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1800373&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.